Gary W Beecham1, Badri Vardarajan1, Elizabeth Blue1, William Bush1, James Jaworski1, Sandra Barral1, Anita DeStefano1, Kara Hamilton-Nelson1, Brian Kunkle1, Eden R Martin1, Adam Naj1, Farid Rajabli1, Christiane Reitz1, Timothy Thornton1, Cornelia van Duijn1, Allison Goate1, Sudha Seshadri1, Lindsay A Farrer1, Eric Boerwinkle1, Gerard Schellenberg1, Jonathan L Haines1, Ellen Wijsman1, Richard Mayeux1, Margaret A Pericak-Vance1. 1. John P. Hussman Institute for Human Genomics (G.W.B., J.J., K.H.-N., B.K., E.R.M., F.R., M.A.P.-V.), University of Miami, Miller School of Medicine; Dr. John T. Macdonald Foundation Department of Human Genetics (G.W.B., E.R.M., M.A.P.-V.), University of Miami, Miller School of Medicine, FL; The Taub Institute for Research on Alzheimer's Disease and the Aging Brain (B.V., S.B., C.R., R.M.), Columbia University; The Gertrude H. Segievsky Center (B.V., S.B., C.R., R.M.), Columbia University, New York Presbyterian Hospital; Division of Medical Genetics (E. Blue, E.W.), Department of Medicine, University of Washington, Seattle; Institute for Computational Biology (W.B., J.L.H.), Case Western Reserve University, Cleveland, OH; Department of Neurology (A.D., S.S., L.A.F.), Boston University School of Medicine; Department of Biostatistics (A.D., S.S., L.A.F.), Boston University School of Medicine, MA; School of Medicine (A.N., G.S.), University of Pennsylvania, Philadelphia; Department of Biostatistics (T.T., E.W.), University of Washington, Seattle; Erasmus Medical University (C.D.), Rotterdam, The Netherlands; Icahn School of Medicine at Mount Sinai (A.G.), New York, NY; Department of Medicine (L.A.F.), Boston University School of Medicine, MA; and University of Texas (E. Boerwinkle), Houston.
Abstract
OBJECTIVE: To identify genetic variation influencing late-onset Alzheimer disease (LOAD), we used a large data set of non-Hispanic white (NHW) extended families multiply-affected by LOAD by performing whole genome sequencing (WGS). METHODS: As part of the Alzheimer Disease Sequencing Project, WGS data were generated for 197 NHW participants from 42 families (affected individuals and unaffected, elderly relatives). A two-pronged approach was taken. First, variants were prioritized using heterogeneity logarithm of the odds (HLOD) and family-specific LOD scores as well as annotations based on function, frequency, and segregation with disease. Second, known Alzheimer disease (AD) candidate genes were assessed for rare variation using a family-based association test. RESULTS: We identified 41 rare, predicted-damaging variants that segregated with disease in the families that contributed to the HLOD or family-specific LOD regions. These included a variant in nitric oxide synthase 1 adaptor protein that segregates with disease in a family with 7 individuals with AD, as well as variants in RP11-433J8, ABCA1, and FISP2. Rare-variant association identified 2 LOAD candidate genes associated with disease in these families: FERMT2 (p-values = 0.001) and SLC24A4 (p-value = 0.009). These genes still showed association while controlling for common index variants, indicating the rare-variant signal is distinct from common variation that initially identified the genes as candidates. CONCLUSIONS: We identified multiple genes with putative damaging rare variants that segregate with disease in multiplex AD families and showed that rare variation may influence AD risk at AD candidate genes. These results identify novel AD candidate genes and show a role for rare variation in LOAD etiology, even at genes previously identified by common variation.
OBJECTIVE: To identify genetic variation influencing late-onset Alzheimer disease (LOAD), we used a large data set of non-Hispanic white (NHW) extended families multiply-affected by LOAD by performing whole genome sequencing (WGS). METHODS: As part of the Alzheimer Disease Sequencing Project, WGS data were generated for 197 NHW participants from 42 families (affected individuals and unaffected, elderly relatives). A two-pronged approach was taken. First, variants were prioritized using heterogeneity logarithm of the odds (HLOD) and family-specific LOD scores as well as annotations based on function, frequency, and segregation with disease. Second, known Alzheimer disease (AD) candidate genes were assessed for rare variation using a family-based association test. RESULTS: We identified 41 rare, predicted-damaging variants that segregated with disease in the families that contributed to the HLOD or family-specific LOD regions. These included a variant in nitric oxide synthase 1 adaptor protein that segregates with disease in a family with 7 individuals with AD, as well as variants in RP11-433J8, ABCA1, and FISP2. Rare-variant association identified 2 LOAD candidate genes associated with disease in these families: FERMT2 (p-values = 0.001) and SLC24A4 (p-value = 0.009). These genes still showed association while controlling for common index variants, indicating the rare-variant signal is distinct from common variation that initially identified the genes as candidates. CONCLUSIONS: We identified multiple genes with putative damaging rare variants that segregate with disease in multiplex AD families and showed that rare variation may influence AD risk at AD candidate genes. These results identify novel AD candidate genes and show a role for rare variation in LOAD etiology, even at genes previously identified by common variation.
Authors: M Bodzioch; E Orsó; J Klucken; T Langmann; A Böttcher; W Diederich; W Drobnik; S Barlage; C Büchler; M Porsch-Ozcürümez; W E Kaminski; H W Hahmann; K Oette; G Rothe; C Aslanidis; K J Lackner; G Schmitz Journal: Nat Genet Date: 1999-08 Impact factor: 38.330
Authors: A Brooks-Wilson; M Marcil; S M Clee; L H Zhang; K Roomp; M van Dam; L Yu; C Brewer; J A Collins; H O Molhuizen; O Loubser; B F Ouelette; K Fichter; K J Ashbourne-Excoffon; C W Sensen; S Scherer; S Mott; M Denis; D Martindale; J Frohlich; K Morgan; B Koop; S Pimstone; J J Kastelein; J Genest; M R Hayden Journal: Nat Genet Date: 1999-08 Impact factor: 38.330
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: A Cenarro; M Artieda; S Castillo; P Mozas; G Reyes; D Tejedor; R Alonso; P Mata; M Pocoví; F Civeira Journal: J Med Genet Date: 2003-03 Impact factor: 6.318
Authors: M Teresa Villarreal-Molina; Carlos A Aguilar-Salinas; Maricela Rodríguez-Cruz; Daniela Riaño; Marisela Villalobos-Comparan; Ramon Coral-Vazquez; Marta Menjivar; Petra Yescas-Gomez; Mina Königsoerg-Fainstein; Sandra Romero-Hidalgo; M Teresa Tusie-Luna; Samuel Canizales-Quinteros Journal: Diabetes Date: 2007-02-07 Impact factor: 9.461
Authors: Yihan Li; Simon M Laws; Luke A Miles; James S Wiley; Xin Huang; Colin L Masters; Ben J Gu Journal: Cell Mol Life Sci Date: 2021-10-27 Impact factor: 9.207
Authors: Diane Xue; William S Bush; Alan E Renton; Edoardo A Marcora; Joshua C Bis; Brian W Kunkle; Eric Boerwinkle; Anita L DeStefano; Lindsay Farrer; Alison Goate; Richard Mayeux; Margaret Pericak-Vance; Gerard Schellenberg; Sudha Seshadri; Ellen Wijsman; Jonathan L Haines; Elizabeth E Blue Journal: Alzheimers Dement (Amst) Date: 2021-12-31
Authors: Liene Bossaerts; Elisabeth Hendrickx Van de Craen; Rita Cacace; Bob Asselbergh; Christine Van Broeckhoven Journal: Acta Neuropathol Commun Date: 2022-03-31 Impact factor: 7.801